FDA Inspection
Hospira, Inc., A Pfizer CompanyHospira, Inc., A Pfizer Company – FDA Inspection, Jun 30, 2023
Record Details
This FDA Inspection record concerns Hospira, Inc., A Pfizer Company, with an inspection on June 30, 2023, issued by the Kansas City District Office.
- Inspection Date
- June 30, 2023
View Company Profile
ID · 6fd69705-8b42-40b4-a56f-c4786c38b469
Inspection Facts
- Inspection number
- 1209308
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Hospira, Inc., A Pfizer Company
19| Date | Classification | Office | Project area |
|---|---|---|---|
| March 10, 2026 | Not classified | Kansas City District Office | |
| January 17, 2025 | VAI | Kansas City District Office | Drug Quality Assurance |
| March 27, 2024 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| January 17, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 15, 2018 | OAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for Hospira, Inc., A Pfizer Company
- FDA Inspection 1310592 - 2026-03-10
- FDA Inspection 1255699 - 2025-01-17
- FDA Inspection 1229140 - 2024-03-27
- FDA Inspection 1115467 - 2020-01-17
- FDA Inspection 1064827 - 2018-08-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.